Salk Institute’s ShortStop revolutionizes genetic search
Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But…
NKAPL identified as a tumor suppressor and therapeutic target in NSCLC
Non-small cell lung cancer (NSCLC) accounts for over 80% of lung cancer cases and is often diagnosed at…
Pfizer Completes Licensing Agreement with 3SBio
Exclusive license to promising investigational cancer immunotherapy complements and strengthens Pfizer’s innovative Oncology portfolio NEW YORK, July 24,…